Jo Patterson News Today

LONDON - Former Zeno London head of corporate and brand communications Sarah Ogden has returned to Zeno Group in the newly-created role of chief clie

The medical cannabis industry’s dream of selling weed prescription-free in Australia’s pharmacies has stalled, as several failed clinical trials force it into a rethink.

Australia's Bod Science has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD medicine. 

The only grocery store in one of  Washington, D.C.'s most economically disadvantaged areas is considering shutting down operations, according to reports.

Ward 8 Council member Trayon White is calling for the Giant along Alabama Avenue, Southeast to remain open so his constituents can access fresh food without traveling to a neighboring ward.

To combat the “summer slide,” a network of about 600 community partners created a robust summer environment throughout the Dallas area to help improve students’ academic and social-emotional development.

DALLAS -- First grader Lillian Moore sat at a cafeteria table alongside mounds of red, yellow and blue clay, eager to create an art piece she could display at home on a bookshelf or bedside table.

Australia's Bod Science Limited (ASX:BOD) has completed its phase IIB clinical trial for a potential Schedule 3 cannabidiol (CBD) product.

Australia's Bod Science Limited (ASX:BOD) has announced a significant medicinal cannabis collaboration with Antah Group.

ASX Health Stocks: Pot stock BOD’s Phase 1 results; Paradigm and Impedimed shake up exec teams